rs115270691

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000346753.9(TMPRSS6):​c.-13C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0265 in 1,614,108 control chromosomes in the GnomAD database, including 634 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 64 hom., cov: 32)
Exomes 𝑓: 0.027 ( 570 hom. )

Consequence

TMPRSS6
ENST00000346753.9 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.37

Publications

3 publications found
Variant links:
Genes affected
TMPRSS6 (HGNC:16517): (transmembrane serine protease 6) The protein encoded by this gene is a type II transmembrane serine proteinase that is found attached to the cell surface. The encoded protein may be involved in matrix remodeling processes in the liver. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
TMPRSS6 Gene-Disease associations (from GenCC):
  • IRIDA syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 22-37103525-G-A is Benign according to our data. Variant chr22-37103525-G-A is described in ClinVar as Benign. ClinVar VariationId is 262723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0626 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMPRSS6NM_001374504.1 linkc.-1-107C>T intron_variant Intron 1 of 17 ENST00000676104.1 NP_001361433.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMPRSS6ENST00000676104.1 linkc.-1-107C>T intron_variant Intron 1 of 17 NM_001374504.1 ENSP00000501573.1 Q8IU80-1

Frequencies

GnomAD3 genomes
AF:
0.0246
AC:
3744
AN:
152198
Hom.:
64
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0242
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.0308
Gnomad ASJ
AF:
0.0309
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00642
Gnomad FIN
AF:
0.00433
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0288
Gnomad OTH
AF:
0.0401
GnomAD2 exomes
AF:
0.0212
AC:
5337
AN:
251246
AF XY:
0.0214
show subpopulations
Gnomad AFR exome
AF:
0.0247
Gnomad AMR exome
AF:
0.0180
Gnomad ASJ exome
AF:
0.0299
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00646
Gnomad NFE exome
AF:
0.0297
Gnomad OTH exome
AF:
0.0269
GnomAD4 exome
AF:
0.0267
AC:
38976
AN:
1461792
Hom.:
570
Cov.:
34
AF XY:
0.0263
AC XY:
19137
AN XY:
727198
show subpopulations
African (AFR)
AF:
0.0239
AC:
800
AN:
33480
American (AMR)
AF:
0.0198
AC:
884
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0276
AC:
721
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0114
AC:
984
AN:
86256
European-Finnish (FIN)
AF:
0.00622
AC:
332
AN:
53334
Middle Eastern (MID)
AF:
0.0681
AC:
393
AN:
5768
European-Non Finnish (NFE)
AF:
0.0297
AC:
33072
AN:
1112000
Other (OTH)
AF:
0.0296
AC:
1789
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2556
5111
7667
10222
12778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1244
2488
3732
4976
6220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0245
AC:
3739
AN:
152316
Hom.:
64
Cov.:
32
AF XY:
0.0230
AC XY:
1717
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.0241
AC:
1002
AN:
41568
American (AMR)
AF:
0.0308
AC:
471
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0309
AC:
107
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00664
AC:
32
AN:
4822
European-Finnish (FIN)
AF:
0.00433
AC:
46
AN:
10618
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0287
AC:
1955
AN:
68028
Other (OTH)
AF:
0.0392
AC:
83
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
198
397
595
794
992
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0236
Hom.:
47
Bravo
AF:
0.0271
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0323
EpiControl
AF:
0.0318

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcytic anemia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.4
DANN
Benign
0.65
PhyloP100
1.4
PromoterAI
0.054
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115270691; hg19: chr22-37499565; API